clinicaltrials.gov
Fuente RSS de ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days
Recibe las últimas novedades de ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days en cuanto se publiquen.
Últimas publicaciones
Lee ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days donde prefieras
Quienes siguen a ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days también siguen
-
Chugai Pharmaceutical: News Releases chugai-pharm.co.jp
-
Regeneron Pharmaceuticals Inc. News Releases investor.regeneron.com
-
What's new ema.europa.eu
-
Roche Media News roche.com
-
Preguntas
¿Cuál es la URL del canal RSS de ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?
La dirección del canal es https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=Bimekizumab&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Pégala en cualquier lector RSS o haz clic en Seguir ahora para leerlo en Feeder.
¿Con qué frecuencia publica ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?
ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days publica aproximadamente una vez a la semana. La última publicación fue hace 2 días.
¿Funciona el canal RSS de ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days?
Sí. Feeder lo comprobó hace 32 minutos y el canal respondió con normalidad.
¿Cómo sigo a ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days en Feeder?
Haz clic en Seguir ahora y regístrate si aún no tienes una cuenta. El plan gratuito de Feeder incluye hasta 200 feeds en la web, iPhone y Android. No se requiere tarjeta de crédito.
Sigue ClinicalTrials.gov: Bimekizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days en Feeder
El plan gratuito de Feeder incluye hasta 200 feeds en la web, iPhone y Android. No se requiere tarjeta de crédito.